Benjamin Basil

President, Lilly Australia & North Asia Pacific - Corporate Athlete - Building Winning Teams

Benjamin L. Basil is a senior executive at Eli Lilly and Company with over 24 years of global experience in the pharmaceutical industry.1 He has held several leadership positions within the company, including:

Senior Vice President, Global Customer Office (as of February 2024)2
President, Eli Lilly China (January 2023 - February 2024)1
President & GM, Australia, NZ, & North Asia Pacific (February 2019 - December 2022)1
US Oncology Marketing Leader (February 2017 - January 2019)1
US Alzheimer's Marketing Leader (January 2016 - January 2017)1

Basil is known for his expertise in executive leadership, blockbuster brand building, launch execution, and business turnarounds.1 He has worked in major markets across four continents, including the US, China, Germany, and Australia.1

Career Highlights

Leadership Style: Basil is recognized for creating a winning team culture and delivering outstanding business results.1
Awards: He has received numerous accolades, including the CEO of the Year - HR Champion Excellence Award in 2021 and multiple President's Awards (2019-2022) from Eli Lilly & Company.1
Background: A former Division I Collegiate Athlete, Basil applies peak performance strategies from sports to help individuals and teams succeed in business.1

Education and Skills

Harvard Business School Executive Education1
Fluent in English and German1
Expertise in pharma marketing, consumer insights, and digital marketing1

Benjamin L. Basil's career at Eli Lilly spans various roles, showcasing his versatility and leadership in the pharmaceutical industry across global markets.1